Whey constituents containing compositions for the preparation of chewable tablets.
CH700941B1
A pharmaceutical composition for the treatment of malaria.
CH699814B1
Diclofenac for topical application as a spray.
CH699254B1
An oral pharmaceutical formulation for pyridylmethylsulfinyl benzimidazoles-containing alumina, and processes for their preparation.
CH698926B1
Powdered vitamin C zinc preparation for oral administration
CH698658B1
An oral pharmaceutical formulation with rapid release for pyridylmethylsulfinyl-benzimidazoles.
CH697390B1
Producing solid oral dosage forms, useful e.g. for combating ulcer, comprises dissolving pyridyl-methyl-sulfinyl-benzimidazole compound in a polyhydroxy compound containing a basic organic compound and filling the solution into capsules
WO2005115352A1
Dry-coating process
EP1781258A1
Formulations of bisphosphonates
CH696870A5
Preparing solid oral dosage form containing e.g. vitamin B12 and folic acid, useful to treat e.g. vascular disease, comprises dissolving vitamin B12 and folic acid in binding agent and mixing with other components and auxiliary material
CH695415A5
Quick decomposing solid oral medicine form, useful in taste-masked medicine and for oral administration of the active agent, comprises an active agent with quick release active agent comprising a granulate and optionally an additive
CH695191A5
Oral pharmaceutical combination of two dose forms comprises proton pump inhibitor and anti-phlogistic, separate dose forms being commonly provided in blister pack
CH694034A5
Diclofenac potassium injection solution.
CH696420A5
New stable formulations of alkyl, phenyl-pyridones for topical use.
AU6552500A
Medicament for treating intestinal diseases
WO0016775A1
Topical formulation of alkyl-, phenyl-pyridone
CZ20001526A3
Pharmaceutically active formulation containing artemisinin and/or artemisinin derivatives
CH692321A5
Pharmaceutically effective composition which comprises an effective anti-malarial parasite substance.
